Tumour-intrinsic mechanisms include a lack of tumour immunogenicity (low tumour mutational burden (TMB), heterogeneous antigens, and mutation of certain genes), loss of tumour antigen expression, loss of HLA expression, aberration in signalling pathways such as those of mitogen-activated protein kinase (MAPK), PI3K, WNT, and IFN, and constitutive PD-L1 expression [21,52,53,54,55]. The gene discussed is WNK2; the disease is neoplasm.